Human papillomavirus and cervical cancer

References

• American College of Gynecologists and Obstetricians (ACOG). 2013. Practice Bulletin No. 140: management of abnormal cervical cancer screening test results and cervical cancer precursors. Obstetrics and Gynecology 122:1338–1367.
   PubMedGoogle Scholar
• American College of Obstetricians and Gynecologists (ACOG). 2017. Committee opinion No. 704: human papillomavirus vaccination. Obstetrics and Gynecology 129:e173–e178.
   PubMed Web of Science ®Google Scholar
• Adam E, Berkova Z, Daxnerova Z, Icenogle J, Reeves WC, Kaufman RH. 2000. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease. American Journal of Obstetrics and Gynecology 182:257–264.
   PubMed Web of Science ®Google Scholar
• Agida T, Akaba G, Isah A, Ekele B. 2015. Knowledge and perception of human papilloma virus vaccine among the antenatal women in a Nigerian tertiary hospital. Nigerian Medical Journal 56:23–27.
   PubMedGoogle Scholar
• Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E. 2001. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. European Journal of Cancer 37:246–250.
   PubMed Web of Science ®Google Scholar
• Appleby P, Beral V, Berrington de Gonzáles A, Colin D, Franceschi S, Green J. 2006. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. International Journal of Cancer 119:1108–1124.
   PubMed Web of Science ®Google Scholar
• Apt D, Watts RM, Suske G, Bernard U. 1996. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transcription correlate with the activation of the HPV-16 promoter. Virology 224:281–291.
   PubMed Web of Science ®Google Scholar
• Autier P, Coibion M, Huet F, Grivegnee AR. 1996. Transformation zone location and intraepithelial neoplasia of the cervix uteri. British Journal of Cancer 74:488–490.
   PubMed Web of Science ®Google Scholar
• Baker TS, Newcomb WW, Olson NH, Cowsert LM, Olson C, Brown JC. 1991. Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophysical Journal 60:1445–1456.
   PubMed Web of Science ®Google Scholar
• Bao YP, Li N, Smith JS, Qiao YL. 2008. ACCPAB members: human papillomavirus type distribution in women from Asia: a meta-analysis. International Journal of Gynecological Cancer 18:71–79.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68:394–424.
   PubMed Web of Science ®Google Scholar
• Brisson J, Morin K, Fortier M, Roy M, Bouchard C, Leclerc J. 1994. Risk factors for cervical intraepithelial neoplasia: differences between low and high-grade lesions. American Journal of Epidemiology 40:700–710.
   Web of Science ®Google Scholar
• Burd EM. 2003. Human papillomavirus and cervical cancer. Clinical Microbiology Reviews 16:1–17.
   PubMed Web of Science ®Google Scholar
• Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, et al. 1996. Declining presence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sexually Transmitted Diseases 23:333–341.
   PubMed Web of Science ®Google Scholar
• Calore EE, Pereira SMM, Cavaliere MJ. 2001. Progression of cervical lesions in HIV-seropositive women: a cytological study. Diagnostic Cytopathology 24:117–119.
   PubMed Web of Science ®Google Scholar
• Capra G, Giovannelli L, Matranga D, Bellavia C, Guarneri MF, Fasciana T, et al. 2017. Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: a referral hospital-based study in Sicily. Human Vaccines and Immunotherapeutics 13:1839–1843.
   PubMed Web of Science ®Google Scholar
• Cárdenas-Turanzas M, Nogueras-Gonzalez GM, Scheurer ME, Adler-Storthz K, Benedet JL, Beck JR, et al. 2008. The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings. Cancer Epidemiology, Biomarkers and Prevention 17:2865–2871.
   PubMed Web of Science ®Google Scholar
• Castle PE. 2004. Beyond human papillomavirus: the cervix, exogenous secondary factors, and the development of cervical precancer and cancer. Journal of Lower Genital Tract Disease 8:224–230.
   PubMedGoogle Scholar
• Catarino R, Petignat P, Dongui G, Vassilakos P. 2015. Cervical cancer screening in developing countries at a crossroad: emerging technologies and policy choices. World Journal of Clinical Oncology 6:281–290.
   PubMed Web of Science ®Google Scholar
• Chua KL, Hjerpe A. 1996. Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma. Cancer 77:121–127.
   PubMed Web of Science ®Google Scholar
• Conely LK, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC. 2002. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminate and intraepithelial neoplasia; a prospective cohort study. Lancet 359:108–113.
   PubMed Web of Science ®Google Scholar
• Cubie HA, Seagar AL, Beattie GJ, Monaghan S, Williams A. 2000. A longitudinal study if HPV detection and cervical pathology in HIV infected women. Sexually Transmitted Infections 76:257–261.
   PubMed Web of Science ®Google Scholar
• de Araujo Souza PS, Villa LL. 2003. Genetic susceptibility to infection with human papillomavirus and development of cervical cancer in women in Brazil. Mutation Research 544:375–383.
   PubMed Web of Science ®Google Scholar
• de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX. 2003. Worldwide Prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. The Lancet Infectious Diseases 7:453–459.
   Web of Science ®Google Scholar
• Denny L. 2012. Cervical cancer: prevention and treatment. Discovery Medicine 14:125–131.
   PubMed Web of Science ®Google Scholar
• Erickson BK, Alvarez RD, Huh WK. 2013. Human papillomavirus: what every provider should know. American Journal of Obstetrics and Gynecology 208:169–175.
   PubMed Web of Science ®Google Scholar
• Ezenwa BN, Balogun MR, Okafor IP. 2013. Mothers’ human papilloma virus knowledge and willingness to vaccinate their adolescent daughters in Lagos, Nigeria. International Journal of Women's Health 5:371–377.
   PubMedGoogle Scholar
• Favre M. 1975. Structural polypeptides of rabbit, bovine, and human papillomaviruses. Journal of Virology 15:1239–1247.
   PubMed Web of Science ®Google Scholar
• Franco EL. 1995. Cancer causes revisited: human papillomavirus and cervical neoplasia. Journal of the National Cancer Institute 87:779–780.
   PubMedGoogle Scholar
• Gichangi P, Estambale B, Bwayo J, Rogo K, Ojwang S, Opiyo A, et al. 2003. Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya. International Journal of Gynecologic Cancer 13:827–833.
   PubMed Web of Science ®Google Scholar
• Giorgi C, Franconi R, Rybicki EP. 2010. Human papillomavirus vaccines in plants. Expert Review of Vaccines 9:913–924.
   PubMed Web of Science ®Google Scholar
• GLOBOCAN. 2012. Database. Cervical cancer: estimated incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer. Lyon, France, [cited 2018 Jul 15].
   Google Scholar
• Harris TG, Burk RD, Palesky JM, Massad S, Bang JY, Anastos K, et al. 2005. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA 293:1471–1476.
   PubMed Web of Science ®Google Scholar
• Harro CD, Pang Y-Y, Roden RBS, Hildesheim A, Wang Z, Reynolds MJ, et al. 2001. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. Journal of the National Cancer Institute 93:284–292.
   PubMed Web of Science ®Google Scholar
• Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. 1998. Natural history of cervicovaginal papillomavirus infection in young women. The New England Journal of Medicine 338:413–428.
   Web of Science ®Google Scholar
• Holcomb K, Abulafia O, Matthews RP, Chapman JE, Borges A, Lee YC, et al. 1999. The significance of ASCUS cytology in HIV-positive women. Gynecologic Oncology 75:118–121.
   PubMed Web of Science ®Google Scholar
• Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, et al. 2015. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Journal of Lower Genital Tract Disease 19:91–96.
   PubMed Web of Science ®Google Scholar
• Jin XW, Cash J, Kennedy AW. 1999. Human papillomavirus typing and the reduction of cervical cancer risk. Cleveland Clinic Journal of Medicine 66:533–539.
   PubMed Web of Science ®Google Scholar
• Juneja A, Sehgal A, Mitra AB, Pandey A. 2003. A survey on risk factors associated with cervical cancer. Indian Journal of Cancer 40:15–22.
   PubMedGoogle Scholar
• Kim HJ, Kim H-J. 2017. Current status and future prospects for human papillomavirus vaccines. Archives of Pharmacal Research 40:1050–1063.
   PubMed Web of Science ®Google Scholar
• Kivistik A, Lang K, Baili P, Anttila A, Veerus P. 2011. Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia. BMC Women's Health 11:43.
   PubMed Web of Science ®Google Scholar
• Leinonen MK, Nieminen P, Lonnberg S, Malila N, Hakama M, Pokhrel A, et al. 2012. Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland. BMJ 345:e7789.
   PubMed Web of Science ®Google Scholar
• Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. 2011. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. International Journal of Cancer 128:927–935.
   PubMed Web of Science ®Google Scholar
• Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2013. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstetrics and Gynecology 121:829–846.
   PubMed Web of Science ®Google Scholar
• Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. 1993. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstetrics and Gynecology 82:578–585.
   PubMed Web of Science ®Google Scholar
• Munagala R, Kausar H, Munjal C, Gupta RC. 2011. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis 32:1697–1705.
   PubMed Web of Science ®Google Scholar
• Okunade KS, Nwogu CM, Oluwole AA, Anorlu RI. 2017. Prevalence and risk factors for genital high-risk human papillomavirus infection among women attending the out-patient clinics of a university teaching hospital in Lagos, Nigeria. Pan African Medical Journal 28:227.
   PubMed Web of Science ®Google Scholar
• Okunade KS, Sunmonu O, Osanyin GE, Oluwole AA. 2017. Knowledge and acceptability of human papillomavirus vaccination among women attending the gynaecological outpatient clinics of a university teaching hospital in Lagos, Nigeria. Journal of Tropical Medicine 2017:1.
   Web of Science ®Google Scholar
• Ostor AG. 1993. Natural history of cervical intraepithelial neoplasia: a critical review. International Journal of Gynecological Pathology 12:186–192.
   PubMed Web of Science ®Google Scholar
• Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG. 2014. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. PLoS ONE 9:e90912.
   PubMed Web of Science ®Google Scholar
• Philips DH, Ni Shé M. 1993. Smoking-related DNA adducts in human cervical biopsies. IARC Scientific Publications 124:327–330.
   Google Scholar
• Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, et al. 2008. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. The Lancet Oncology 9:929–936.
   PubMed Web of Science ®Google Scholar
• Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, et al. 2014. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up four European randomised controlled trials. The Lancet 383:524–532.
   PubMed Web of Science ®Google Scholar
• Rybicki EP. 2014. Plant-based vaccines against viruses. Virology Journal 11:205.
   PubMed Web of Science ®Google Scholar
• Sapp M, Volpers C, Muller M, Streeck RE. 1995. Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles. Journal of General Virology 76:2407–2412.
   PubMed Web of Science ®Google Scholar
• Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. 2012. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. American Journal of Clinical Pathology 137:516–542.
   PubMed Web of Science ®Google Scholar
• Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. 2007. Human papillomavirus and cervical cancer. Lancet (London, England) 370:890–907.
   PubMed Web of Science ®Google Scholar
• Schiffman M, Wentzensen N. 2013. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiology, Biomarkers and Prevention 22:553–560.
   PubMed Web of Science ®Google Scholar
• Shields TS, Brinton LA, Burk RD, Wang SS, Weinstein SJ, Ziegler RG, et al. 2004. A case-control study of risk factors for invasive cervical cancer among US women exposed to oncogenic types of human papillomavirus. Cancer Epidemiology, Biomarkers and Prevention 13:1574–1582.
   PubMed Web of Science ®Google Scholar
• Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, Ngendahayo L, et al. 2009. Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. The Journal of Infectious Diseases 199:1851–1861.
   PubMed Web of Science ®Google Scholar
• Stanley MA, Pett MR, Coleman N. 2007. HPV: from infection to cancer. Biochemical Society Transactions 35:1456–1460.
   PubMed Web of Science ®Google Scholar
• Syrjänen KJ. 1996. Natural history of genital human papillomavirus infections. In: Lacey C, editor. Papillomavirus reviews. Leeds (UK): Leeds University Press. p. 189–206.
   Google Scholar
• Torrisi A, Del Mistro A, Onnis GL, Merlin F, Bertorelle R, Minucci D. 2000. Colposcopy, cytology and HPV testing in HIV-positive and HIV-negative women. European Journal of Gynaecological Oncology 21:168–172.
   PubMed Web of Science ®Google Scholar
• Unger ER, Eliav B. 2004. Human papillomavirus and cervical cancer. Emerging Infectious Diseases 10:2031–2032.
   PubMed Web of Science ®Google Scholar
• Vici P, Pizzuti L, Mariani L, Zampa G, Santini D, Di Lauro L, et al. 2016. Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies. Expert Review of Vaccines 15:1327–1336.
   PubMed Web of Science ®Google Scholar
• Villa LL. 1997. Human papillomaviruses and cervical cancer. Advances in Cancer Research 71:321–341.
   PubMed Web of Science ®Google Scholar
• Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of Pathology 189:12–19.
   PubMed Web of Science ®Google Scholar
• WHO. 2014. HPV vaccination. In: Comprehensive cervical cancer control – a guide to essential practice. 2nd ed. Geneva, Switzerland: WHO Press. p. 110–128.
   Google Scholar
• WHO. 2009. World Health Organization human papillomavirus vaccines WHO position paper. The Weekly Epidemiological Record 15:117–132.
   Google Scholar
• Williams VM, Filippova M, Soto U, Duerksen-Hughes PJ. 2011. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virology 6:45–57.
   PubMed Web of Science ®Google Scholar
• Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. 2015. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecologic Oncology 136:189–197.
   PubMed Web of Science ®Google Scholar
• Yang A, Farmer E, Wu TC, Hung C-F. 2016. Perspectives for therapeutic HPV vaccine development. Journal of Biomedical Science 23:75.
   PubMed Web of Science ®Google Scholar
• Yang X, Jin G, Nakao Y, Rahimtula M, Pater MM, Pater A. 1996. Malignant transformation of HPV-16 immortalized human endocervical cells by cigarette smoke condensate and characterization of multistage carcinogenesis. International Journal of Cancer 65:338–344.
   PubMed Web of Science ®Google Scholar
• Zhang J-J, Cao X-C, Zheng X-Y, Wang H-Y, Li Y-W. 2018. Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer. Journal of International Medical Research 46:1033–1042.
   PubMed Web of Science ®Google Scholar